NERV

Value 20202021202220232024 TTM Total revenue 41.18 M0000 -25.35 K Gross profit 41.18 M0000 -25.35 K Operating expenses 39.33 M45.37 M25.23 M23.12 M21.85 M 14.64 M Selling/general/admin expenses 17.29 M13.33 M10.58 M10.41 M9.95 M 9.07 M Research & development 22.04 M32.04 M14.65 M12.71 M11.9 M 5.57 M Operating income 1.85 M-45.37 M-25.23 M-23.12 M-21.85 M -14.64 M Non-Operating Income, Total 180.8 K-16.33 K529.2 K1.4 M1.27 M 615.97 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 180.8 K-16.33 K529.2 K1.4 M1.27 M 615.97 K Unusual income/expense ————— — Pretax income 1.94 M-51.71 M-32.11 M-21.72 M-20.58 M -14.03 M Equity in earnings ————— — Taxes -1.3 M-1.8 M-8.8 M-6.8 M-800 K — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 1.94 M-49.91 M-32.11 M-30.01 M1.44 M -14.03 M Discontinued operations ————— — Net income 1.94 M-49.91 M-32.11 M-30.01 M1.44 M -14.03 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 1.94 M-49.91 M-32.11 M-30.01 M1.44 M -14.03 M Basic earnings per share (Basic EPS) 0.4-9.36-6.01-4.610.19 -1.85 Diluted earnings per share (Diluted EPS) 0.4-9.36-6.01-4.610.19 -1.85 Average basic shares outstanding 5.1 M5.34 M5.34 M6.51 M7.57 M 30.28 M Diluted shares outstanding 5.11 M5.34 M5.34 M6.51 M7.57 M 30.28 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 16.01 K16.01 K——— —